Literature DB >> 3659114

Cholinergic and non-cholinergic components of the inotropism evoked by electric field stimulation in the isolated rat urinary bladder. Influence of some eicosanoids.

G Dveksler1, M F Gimeno, A L Gimeno.   

Abstract

The present study explores whether some arachidonic acid (AA) metabolites formed via cyclo-oxygenase or lipoxygenase pathways influence the inotropism of isolated rat urinary bladders evoked by electric field stimulation (EFS), both in presence of or in absence of atropine. The EFS consisted in square wave pulses of 5 Hz, 5 msec duration and supramaximal voltage, applied every 3 min for a period of 10 sec. Acetylsalicylic acid (ASA) at 10(-4) M, decreased around 30% the magnitude of inotropic responses to EFS and prostaglandin E2 (PGE2, partially at 10(-9) M and fully at 10(-8) M), restored control inotropic levels. PGI2 was also active but only at 10(-7) M; whereas PGF2 alpha, at all concentrations tested (10(-9)-10(-7) M), failed to counteract the diminishing effect of ASA. Moreover, dose-response curves for added acetylcholine (ACh) were not modified by ASA. On the other hand, in presence of atropine (10(-5) M), a diminution of around 40% in the magnitude of control responses to EFS, was detected and when ASA (10(-4) M) was added to atropine-exposed preparations, the atropine resistant component of the EFS-evoked inotropism, was reduced around 30%. Although recovering effects of added PGs were again observed, they were not identical to those observed in absence of atropine. Indeed, PGE2 fully restored the magnitude of contractile responses but it did so only at concentrations 10 times higher than without the cholinergic receptor blocker. On the other hand, PGI2 as well as PGF2 alpha, even at 10(-7) M, were devoid of significant influence. In determining whether lipoxygenase products of AA were also able to modulate the EFS-evoked inotropism, tissue preparations were incubated with nordihydroguaiaretic acid (NDGA), an inhibitor of lipoxygenases, and tested for contractile responses to electric stimulation. NDGA (10(-7) M), failed to alter rat urinary bladder inotropic response to EFS, both in presence of or in absence of atropine. Results suggest that the cholinergic, as well as the non-cholinergic components of the EFS-evoked contractions in isolated rat urinary bladders, are modulated by some cyclo-oxygenase formed AA metabolites, particularly certain PGs, like PGE2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3659114     DOI: 10.1016/0031-6989(87)90087-7

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN: 0031-6989


  5 in total

1.  Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro.

Authors:  M H Hawthorn; C R Chapple; M Cock; R Chess-Williams
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium.

Authors:  Melinda Wuest; Susann Kaden; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-11       Impact factor: 3.000

3.  The effect of inflammation on rat urinary bladder-dependent relaxation in coaxial bioassay system.

Authors:  K Inci; U B Ismailoglu; A Sahin; A Sungur; I Sahin-Erdemli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-25       Impact factor: 3.000

4.  RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Chronic Hepatitis and Acute-on-chronic Liver Failure Caused By HBV.

Authors:  Jiajia Chen; Qingsheng Xu; Yan Zhang; Huafen Zhang
Journal:  Sci Rep       Date:  2020-01-30       Impact factor: 4.379

5.  β3 Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide.

Authors:  Emma Mitidieri; Annalisa Pecoraro; Erika Esposito; Vincenzo Brancaleone; Carlotta Turnaturi; Luigi Napolitano; Vincenzo Mirone; Ferdinando Fusco; Giuseppe Cirino; Raffaella Sorrentino; Giulia Russo; Annapina Russo; Roberta d'Emmanuele di Villa Bianca
Journal:  Antioxidants (Basel)       Date:  2022-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.